Current Use, Monitoring and Reversal of Neuromuscular Block in Pediatric Anesthesia and Intensive Care: A Web‐Based Cross‐Sectional ESAIC Survey
Giulia Bonatti, Mirjana Gander, Arash Afshari, Francis Veyckemans, Thomas Fuchs‐Buder, Thomas Riva, Markus Huber, Nicola Disma, Alexander Fuchs · 2026
Read Current Use, Monitoring and Reversal of Neuromuscular Block in Pediatric Anesthesia and Intensive Care: A Web‐Based Cross‐Sectional ESAIC Survey by Giulia Bonatti, Mirjana Gander, Arash Afshari, Francis Veyckemans, Thomas Fuchs‐Buder, Thomas Riva, Markus Huber, Nicola Disma, Alexander Fuchs (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13639220.txt.
Description
Giulia Bonatti and eight colleagues survey child anesthesia practice on muscle-blocking drugs across many countries, in a paper dated twenty twenty-six. Such drugs ease tube placement in children, and European guidelines back their use. The web survey drew 874 usable replies from staff in forty-three countries, most in Europe. It asked which drugs are used, how their effect is monitored, and how they are reversed.
One drug, rocuronium, led for both routine and emergency tube placement. Blocking drugs were used always or mostly in only about half of newborn and infant cases. A third of staff rarely or never used them for newborns. The authors say real practice lags the guidelines.
Catalog record
| CREATOR | Giulia Bonatti, Mirjana Gander, Arash Afshari, Francis Veyckemans, Thomas Fuchs‐Buder, Thomas Riva, Markus Huber, Nicola Disma, Alexander Fuchs |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |